UK Renal Registry Chooses InterSystems HealthShare for Chronic Kidney Disease Monitoring and Reporting in Britain

InterSystemsInterSystems, a global leader in software for connected care, today announced that the UK Renal Registry has chosen InterSystems HealthShare® as its new national health informatics platform, gathering data from 84 adult and paediatric renal units, plus satellite haemodialysis units, on over 56,000 patients suffering from stage 5 chronic kidney disease (CKD). HealthShare will allow the Renal Registry to collect near real-time information on patients, helping to improve standards of care across the country through greater data accuracy and more regular, consistent reporting on renal unit performance.

The UK Renal Registry consolidates the collection and analysis of standardised data relating to the incidence, clinical management, and outcome of renal disease to ensure high levels of care at NHS renal units, measured against the standards set by the UK Renal Association. Previously, this information was gathered by disparate IT systems and fed into the UK Renal Registry on a quarterly basis, where it was manually validated, analysed and published in the Registry’s annual report. However, with the implementation of HealthShare, the UK Renal Registry will now:

  • Have a daily data feed
  • Reduce the need for human validation and achieve greater accuracy and consistency of reporting
  • Be able to produce detailed quarterly reports, providing units with greater clarity on their performance
  • More easily track and maintain individual patient records.

Using HealthShare, the Registry will make it easier for clinicians to monitor patient treatment, enabling them to instantly access a patient’s renal data, even if they do not have an existing renal record at that particular treatment centre. This is particularly important for patients moving between transplant and dialysis units and those on holiday, as their treatment can be more accurately tracked and reported, reducing the risk of errors and unnecessary duplicate tests.

Ron Cullen, Director at the UK Renal Registry, said, "The UK Renal Registry is a charitable organisation funded by the NHS and tasked with understanding the care chronic kidney disease patients receive. InterSystems' international reputation and experience with strategic interoperability in healthcare means it is the ideal partner to update our informatics systems nationally and ready our service for the future.

"InterSystems HealthShare will allow us to gather more data, more accurately. The platform will also help us achieve our ambition to expand the registry to over 1 million CKD sufferers, which will include not just stage 5 patients, but also stages 2 to 4. We also hope to use the platform to build new tools for clinicians and patients, such as a medicine reconciliation function, which will improve patient care as well as providing cost savings for the NHS," Cullen added.

Steve Garrington, Vice President, International, InterSystems, commented: "We are delighted that the UK Renal Registry has chosen the InterSystems HealthShare health informatics platform to help clinicians capture, share, understand, and act upon their data in a more timely manner. The Registry provides an invaluable service, and HealthShare will support its goal to improve the quality of care for renal patients in Britain."

The Registry chose HealthShare because of its scalability, the time and cost savings from improved data accuracy, and its ability to provide near real-time data. The implementation is being completed by UK Renal Registry staff.

Related news articles:

About InterSystems
InterSystems develops advanced software technologies that enable breakthroughs. Through its data management, integration, and analytics technologies, InterSystems is dedicated to helping clients and partners succeed by deriving meaning and value from data. InterSystems is the global leader in software for connected healthcare, and industries with extreme performance requirements, including high-volume financial trading, energy, and government, rely on InterSystems software. Founded in 1978, privately held InterSystems is headquartered in Cambridge, Massachusetts (USA), with offices worldwide serving clients and partners in more than 100 countries.

About The Renal Registry UK
The Renal Registry is non-profit making and as part of the Renal Association is registered as a charitable activity by the Charity Commission.

The Registry was established by the Renal Association with support from the Department of Health, the British Association of Paediatric Nephrologists, and the British Transplant Society as a resource for the development of patient care in renal disease. It provides a focus for the collection and analysis of standardised data relating to the incidence, clinical management and outcome of renal disease. The UK Renal Registry monitors indicators of the quality as well as quantity of care, with the aim of improving the standard of care.

The Registry provides data for participating renal units, NHS Trusts, commissioning authorities, regional offices, patient groups and researchers. The development of the Registry is open to influence by all interested parties including clinicians, Trusts, commissioning authorities, patient organisations and researchers.

Most Popular Now

AI also Assesses Dutch Mammograms Better…

AI is detecting tumors more often and earlier in the Dutch breast cancer screening program. Those tumors can then be treated at an earlier stage. This has been demonstrated by...

RSNA AI Challenge Models can Independent…

Algorithms submitted for an AI Challenge hosted by the Radiological Society of North America (RSNA) have shown excellent performance for detecting breast cancers on mammography images, increasing screening sensitivity while...

Head-to-Head Against AI, Pharmacy Studen…

Students pursuing a Doctor of Pharmacy degree routinely take - and pass - rigorous exams to prove competency in several areas. Can ChatGPT accurately answer the same questions? A new...

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

Routine AI Assistance may Lead to Loss o…

The introduction of artificial intelligence (AI) to assist colonoscopies is linked to a reduction in the ability of endoscopists (health professionals who perform colonoscopies) to detect precancerous growths (adenomas) in...